Akso Health Group.
AHG.US | Wholesale of other household goods
Akso Health Group is a holding company that operates through its subsidiaries, primarily focusing on the distribution of pharmaceutical products and medical devices. The company is involved in the wholesale distribution of a wide range of healthcare products, including prescription drugs, over-the-c...Show More
Better Health for All
10
Akso Health Group's core business is entirely focused on healthcare, including medical technology, medical devices, oncology services, and online medical consultations, providing exceptional health benefits.
1
The company has no reported revenue from products with negative health outcomes. It is investing significantly in health innovation, with $175.7 million in advances for capital expenditures related to its Internet Hospital platform as of September 30, 2025, and integrating AI for medical consultation and diagnosis.
2
The company engages in chronic disease management through online consultations and sold Covid-19 Antigen Rapid Tests in the U.S. market, demonstrating a focus on preventative health measures.
3
While the company launched an exploratory global patient support initiative on February 3, 2026, aiming to provide free in-hospital treatment plans for up to 10,000 eligible cancer patients, there is insufficient data to score the overall price accessibility, vulnerable reach, or health equity programs against the rubric's quantitative thresholds.
4
Fair Money & Economic Opportunity
0
Akso Health Group's primary business is the wholesale distribution of pharmaceutical products and medical devices to healthcare providers, not consumer financial services. While the company previously operated a micro-lending business, it was discontinued in October 2019.
1
Therefore, there is no current evidence regarding consumer lending activities, pricing, fee structures, or financial inclusion initiatives for underserved populations. All KPIs related to consumer financial services are scored as 'Not applicable' or 'No direct impact' based on the company's current business model.
Fair Pay & Worker Respect
0
No specific, quantifiable evidence for Akso Health Group (AHG.US) regarding any of the 'Fair Pay & Worker Respect' KPIs was found in the provided articles.
1
pertains to Aker Solutions, not AHG.US.
2
The remaining articles either discuss general industry trends or explicitly state that data for these metrics is not mentioned or available for AHG.US.
3
Fair Trade & Ethical Sourcing
0
The provided articles, primarily financial filings, do not contain any specific data or information related to Akso Health Group's fair trade and ethical sourcing practices.
1
There is no evidence regarding fair-trade certifications, supplier audit frequencies, incidents of forced or child labor, supply chain traceability, remediation speeds for violations, ethical clauses in supplier contracts, the share of high-risk materials, or supplier diversity spend.
2
Honest & Fair Business
0
Akso Health Group announced a delay in filing its Form 20-F (Yearly Report) for the financial period ending March 31, 2025.
1
The company expects to file the report within fifteen calendar days following the original due date and does not anticipate significant changes in financial results from the previous fiscal year.
2
Kind to Animals
0
Akso Health Group (AHG.US) is a distributor of pharmaceutical products and medical devices. According to crueltyfreeinvesting.org, the company engages in "No Animal Exploitation."
1
This indicates that AHG.US does not conduct animal testing, use animal-derived ingredients, operate animal husbandry, or engage in activities that directly impact wildlife habitats. Therefore, all KPIs related to animal testing, animal-derived inputs, humane certifications for animal operations, animal agriculture practices, and wildlife conservation are not applicable to its core business model.
No War, No Weapons
0
The provided articles do not contain any specific, concrete data points or facts related to Akso Health Group's involvement with arms manufacturing, military contracts, dual-use technologies, sales to sanctioned regimes, peacebuilding investments, or any other metrics relevant to the "No War, No Weapons" ethical value.
1
The articles explicitly state that no data is available for any of the requested metrics.
2
Planet-Friendly Business
-20
In 2023, Akso Health Group sourced 43.2% of its operational energy consumption from renewables.
1
The company's water consumption was 718.75 m³ per $1 million in revenue for 2023.
2
Additionally, AHG achieved a waste recycling rate of 67.4% in 2023.
3
No environmental compliance violations, regulatory actions, or fines were mentioned for 2023.
4
Respect for Cultures & Communities
0
No evidence available to assess Akso Health Group on Respect for Cultures & Communities.
Safe & Smart Tech
-40
Akso Health Group complies with GDPR, HIPAA, and CCPA, which are considered all required certifications for its industry.
1
The company also complies with FDA, EMA, and PMDA regulations.
2
It invests $18 million annually in data protection compliance and $42 million in quality management compliance.
3
No regulatory violations, fines, or compliance issues were mentioned.
4
Zero Waste & Sustainable Products
0
No evidence available to assess Akso Health Group on Zero Waste & Sustainable Products.